SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marqeta, Inc. – MQ
NEW YORK, Nov. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ: MQ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Airship AI Holdings, Inc. – AISP
NEW YORK, Nov. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Airship AI Holdings, Inc. (“Airship AI” or the “Company”) (NASDAQ: AISP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-58
Busan’s Efforts to Protect the Earth Through MICE Sustainability
BUSAN, South Korea, Nov. 26, 2024 /PRNewswire/ — The MICE industry is one of the many contributors to environmental degradation. The air and ground travel that bring visitors to MICE events around the world contributes to carbon emissions, while the waste generated at MICE events is another m
AccuRadio Shields Listeners from ‘The Little Drummer Boy’ in 2024 Challenge
CHICAGO, Nov. 25, 2024 /PRNewswire/ — This holiday season, AccuRadio, one of the world’s leading online radio services, is stepping up to protect listeners from the ultimate seasonal pitfall: Hearing the song “The Little Drummer Boy.” This Christmas, AccuRadio is helping mus
Meta, Watsons Hong Kong, Hong Kong Life and OPTICAL 88 unlocked WhatsApp potential with Omnichat
Create end-to-end customer journeys using WhatsApp Flows and ads that click to WhatsApp with Meta to accelerate business growth Redefine customer engagement with Omnichat’s WhatsApp membership system and enhance campaign tracking and optimisation through the Conversions API Watsons Hong Kong i
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
YONGIN, South Korea, Nov. 25, 2024 /PRNewswire/ — GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with ‘GC1130A’, an innovative new drug for Sanfillippo syndrome type A (MPS IIIA). GC Biopharma and Novel
Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreement
Adcendo ApS exercises its option to utilize Duality Biologics’ platform to further enhance its first-in-class ADC pipeline PRINCETON, N.J., SHANGHAI and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ — Duality Biologics (“Duality”), a clinical-stage biotech company focusing on the
The Inner Circle acknowledges, Phyllis Heffner, MD as a Pinnacle Professional Member Inner Circle of Excellence
COLUMBIA, Md., Nov. 25, 2024 /PRNewswire/ — Prominently featured in The Inner Circle, Phyllis Heffner, MD is being acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions in the medical field. Phyllis Heffner, MD, a distinguished psychiatrist specializin
The Inner Circle acknowledges, Richard Berrouet as an Inner Circle Lifetime
MCKINNEY, Texas, Nov. 25, 2024 /PRNewswire/ — Prominently featured in The Inner Circle, Richard Berrouet is acknowledged as an Inner Circle Lifetime for his contributions to Pioneering Banking Security Leadership with a Legacy of Military Service and Family Dedication. Richard Berrouet, Secur
The Inner Circle acknowledges, Frances Iger Laterman as a Pinnacle Professional Member
NEW YORK, Nov. 25, 2024 /PRNewswire/ — Prominently featured in The Inner Circle, Frances Iger Laterman is acknowledged as a Pinnacle Professional Member for her contributions in Pioneering Classical Contemporary Art. Frances Iger Laterman, a distinguished figure in the world of classical conte
